David M. Rubenstein

Insider Reports History

Entity
Individual
Location
C/O The Carlyle Group L.P., 1001 Pennsylvania Avenue, Nw, Washington, DC
Signature
/s/ Brian Sandstrom, As Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David M. Rubenstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Carlyle Group Inc. Director Common Stock 29.2M $1.22B $41.74 Jun 6, 2022 Direct
Moderna, Inc. Director Restricted Stock Units 677 $82.3K $121.62 Aug 5, 2024 Direct
Moderna, Inc. Director Stock Option (Right to Buy) 4.07K Aug 5, 2024 Direct

Insider Reports Filed by David M. Rubenstein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRNA Moderna, Inc. Aug 5, 2024 4 $0 4 Aug 7, 2024 Director
MRNA Moderna, Inc. Aug 5, 2024 0 $0 3 Aug 7, 2024 Director
CG Carlyle Group Inc. Jun 6, 2022 1 -$77.3M 4 Jun 6, 2022 Director
CG Carlyle Group Inc. Nov 9, 2021 1 -$116M 4 Nov 10, 2021 Director
CG Carlyle Group Inc. Aug 11, 2021 3 -$188M 4 Aug 13, 2021 Director
CG Carlyle Group Inc. May 18, 2021 1 -$83.5M 4 May 19, 2021 Director, 10%+ Owner